⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GUTS News
Fractyl Health, Inc. Common Stock
Fractyl Health to Participate in Upcoming Investor Events
globenewswire.com
GUTS
Form 8-K
sec.gov
GUTS
Fractyl Health Reports Positive Randomized Data from REMAIN-1 Midpoint Cohort Demonstrating Durable Weight Maintenance One Year After GLP-1 Discontinuation
globenewswire.com
GUTS
Form 8-K
sec.gov
GUTS
Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure
globenewswire.com
GUTS
Fractyl Health Appoints Mike Zumdahl as Senior Vice President, Market Access and Commercial Strategy
globenewswire.com
GUTS
Form 8-K
sec.gov
GUTS
Fractyl Health Reports First Quarter 2026 Financial Results and Business Updates
globenewswire.com
GUTS
Form 8-K
sec.gov
GUTS
Fractyl Health Authorized to Initiate First-in-Human Trial of RJVA-001 in the Netherlands: First Gene Therapy Candidate to Enter Clinical Development for Type 2 Diabetes
globenewswire.com
GUTS